Anne Parker (Tianjin) Technology Co., Ltd
admin@hepacleanroomfilter.com
Home News Industry News Pharmaceutical Industry Clean Room Classification

Industry News

Pharmaceutical Industry Clean Room Classification

Pharmaceutical Industry Clean Room Classification

The air cleanliness level of the relevant processes and environmental areas of drug production shall comply with the requirements of the current national Drug Production Quality Management Practice and Appendix A.

When there are multiple processes in the medical clean room (area), the corresponding air cleanliness level should be adopted according to the production process requirements.

Under the premise of meeting the requirements of the production process, the air flow pattern of the medical clean room should be a combination of local purification in the work area and the whole room air purification.

The air cleanliness level of various pharmaceutical production processes in the production environment should follow the relevant regulations and refer to Table 1-5.

The standard regulations of suspended particles at all levels of the pharmaceutical industry are shown in Table 1-6.

Table 1-5 Air cleanliness level of pharmaceutical production process production environment (1)

Air cleanliness grade Process drug classification

Example

B+A

C+A

B

C

D

Sterile drug

Final sterilizing drug

 

Large volume injection (50ml)

 

Product filling or potting

capping

High contamination risk *2 Preparation and filtration of products

Preparation of materials before filling

High contamination risk*1 Filling or potting of products

Preparation, filling or potting of ophthalmic preparations, aseptic plasters, aseptic suspensions, etc

Product preparation and filtration (concentrated or thin in closed systems)

Disposal of packaging materials and utensils in direct contact with pharmaceuticals after final cleaning

Final cleaning of packaging materials and utensils in direct contact with pharmaceuticals

 

The operation and operation of the product under the condition of incomplete sealing *3, such as product filling or filling, subpacking, stuffing, capping *4, etc

 

Transshipment of products in a fully sealed container in an incomplete sealed *3 state

Formulation of a liquid medicine or product that can be sterilized and filtered before filling

Final cleaning, assembly or packaging, sterilization of packaging materials and utensils that come into direct contact with pharmaceuticals

Preparation of liquid medicine or products that cannot be filtered before filling

Non-final sterilizing drug

Packaging materials in direct contact with pharmaceutical products, assembly of sterilized utensils, and transport and storage under incomplete seal conditions

 

The transfer and storage of packaging materials and utensils in direct contact with drugs in completely sealed containers after sterilization

Product filtration

Crushing, sieving, mixing and packaging of sterile apis

 Note:

1. The high risk of contamination here refers to the situation that the product is easy to grow bacteria, the filling speed is slow, the filling container is a wide-mouth bottle, and the window must be exposed for a few seconds before it can be sealed;

2. The high risk of contamination here means that the product is easy to grow bacteria, it takes a long time to sterilize after preparation, or it is not prepared in a closed window;

3. The product shall be deemed to be in an incomplete sealed state before rolling;

4. According to the tightness of the covered product, the design of the rolling equipment, the characteristics of the aluminum cover and other factors, the rolling operation can be selected in the class A air supply environment under the background of class C or D. Class A air supply environment should at least meet the static requirements of class A area.

 Table 1-5 Air cleanliness level of pharmaceutical production process production environment (2)

Air cleanliness grade Process drug classification

Example

B+A

C+A

B

C

D

Non-sterile drug

 

 

 

 

 

Exposure procedure for non-final sterilization of oral liquid drugs

Exposure procedure for final sterilization of oral liquid products

Exposure procedure for ophthalmic drugs

Exposure procedure for oral solid drugs

Exposure procedure for topical drugs

Exposure procedure for endovascular drugs other than rectal drugs

Exposure procedure for rectal medication

Exposure process for the final disposal of packaging materials that come into direct contact with the above drug products

The exposure process for the final handling of packaging materials and appliances that come into direct contact with the above drug products

Bulk drug

Sterile apis

Refined, dry, packaged exposure environment

 

 

 

 

Non-sterile apis

 

 

 

 

Refined, dry, packaged exposure environment

Biological product

Products not filtered by sterilization before filling

Preparation, combination, potting, freeze-drying, plugging, adding stabilizer, adjuvant, inactivator, etc

 

 

 

 

Products filtered by sterilization before filling

potting

 

Preparation, combination, refining, adding stabilizer, adjuvant, inactivation agent, dedrug filtration, ultrafiltration, etc

 

 

 

 

 

 

The combination of raw plasma

 

 

 

 

 

Non-low temperature extraction

 

 

 

 

 

Pasteurize before subpacking

 

 

 

 

 

capping

 

 

 

 

 

Final container cleaning, etc

 

Table 1-5 Air cleanliness level of pharmaceutical production process production environment (3)

Air cleanliness grade Process drug classification

Example

B+A

C+A

B

C

D

Biological product

Oral preparation

 

 

 

Fermentation, culture closed system

 

Enzyme-linked immunosorbent reagent

 

 

 

Packaging, mixing, packaging, drying

 

In vitro immunoreagent

 

 

 

Production environment

 

Products for deep tissue and large surface wounds

 

 

 

Preparation and filling

 

Radioactive drug

Sterile drug

Requirements related to sterile drugs

Non-sterile drug

 

 

 

Requirements related to non-sterile drugs

Sterile apis

Same as sterile apis

Non-sterile apis

 

 

 

Same as non-sterile apis

Radioimmunoassay box components

 

 

 

 

preparation

Traditional Chinese medicine

Non-wound preparation for external use

 

 

 

 

preparation

Direct use of pure medicinal materials, dry paste

potting

 

 

 

Mix, crush, mix, sift

Sterile drug

Requirements related to sterile drugs

 

 

 

 

 

Requirements for sterile drugs in Central Africa

 

Table 1-6 Standard requirements for suspended particles at all levels of the pharmaceutical industry

Rank

Static

Dynamic[3]

Maximum allowable number of suspended particles/m³

0.5um

5.0um[2]

0.5um

5.0um

A[1]

3520

20

3520

20

B

3520

29

352000

2900

C

352000

2900

3520000

29000

D

3520000

29000

unspecified

unspecified

Note:

1. In order to determine the grade of the eight-level zone, the sampling volume of each sampling point shall not be less than 1m3. The airflow speed is 0.3m/s~0.54m/s.

2. When confirming the level, a short portable dust particle counter should be used; Dynamic sampling heads should be used in unidirectional flow systems.

3. It can be routinely operated and tested during the media simulation filling process to prove that it has reached the dynamic level, but the culture simulation test requires dynamic testing under the "worst condition".

 (Training Materials for Clean Room Engineers)